From: Post COVID-19 syndrome in a prospective cohort study of Egyptian patients
Ā | PCFS (1.5 Months) | OR (95 CI%) | Test of significance | |||
---|---|---|---|---|---|---|
No | Yes | |||||
Mean Ā± SD, N (row %) | Mean Ā± SD, N (row %) | Value | p value | Sig. | ||
Age | 42.68 Ā± 14.66 | 62.44 Ā± 12.05 | Ā | t = ā8.923 | < 0.001 | S |
Sex | ||||||
āMale | 24 (37.5%) | 40 (62.5%) | 1.167 (0.61ā2.2) | X2 = 0.219 | 0.64 | NS |
āFemale | 36 (33.96%) | 70 (66.04%) | ||||
Co-morbidities | ||||||
āNo | 38 (66.67%) | 19 (33.33%) | 8.273 (4.0ā17.0) | X2= 36.957 | <0.001 | S |
āYes | 22 (19.47%) | 91 (80.53%) |